Volume 198, Issue 3 , Pages 265.e1-265.e7, March 2008
The effect of ultralow-dose transdermal estradiol on sexual function in postmenopausal women
Objective
This study was undertaken to examine the effect of ultralow-dose transdermal estradiol on sexual function in postmenopausal women.
Study Design
Analysis of data from a multicenter, randomized, double-blind, placebo-controlled trial of a 0.014 mg/day transdermal estradiol patch in 417 women aged 60 to 80 years. Sexual function was assessed by self-administered questionnaires at baseline and 4, 12, and 24 months. A linear effects model was used to assess treatment effects using data from all on-study assessments.
Results
Women randomly assigned to estradiol had a 4.3 point greater improvement in the vaginal pain/dryness domain relative to placebo (95% CI = 0.3-8.4, P = .04). No significant differences in frequency of sexual activity or other sexual function domains (desire, satisfaction, problems, or orgasm) were observed between treatment groups (P ≥ .10 for all).
Conclusions
Ultralow-dose estradiol resulted in modest improvement in sexual function related to vaginal pain and dryness, but not in other domains of sexual function.
Key words: dyspareunia, estradiol, sexual function, menopause, testosterone, vaginal dryness
To access this article, please choose from the options below
This research was supported in part by a grant from Berlex Laboratories, Inc and by Grant KLZRR024130 from the National Center for Research Resource, a component of the NIH.
Cite this article as: Huang AJ, Yaffe K, Vittinghoff E, et al. The effect of ultralow-dose transdermal estradiol on sexual function in postmenopausal women. Am J Obstet Gynecol 2008;198:265.e1-265.e7.
PII: S0002-9378(07)01183-0
doi:10.1016/j.ajog.2007.09.039
© 2008 Mosby, Inc. All rights reserved.
Volume 198, Issue 3 , Pages 265.e1-265.e7, March 2008
